Osteoporosis Experts Discuss Bisphosphonate Holidays
New Findings on Hydroxychloroquine, Denosumab
Targeted Vertebral Fracture Assessment
Bisphosphonates Reduce Bone Toughness Over Time
Abaloparatide vs. Alendronate for Osteoporosis
U.S. Hip Fracture Incidence Declines with Reductions in Smoking & Drinking
Denosumab Dosing Delays Tied to Increased Fracture Risk
Bone Density Concerns: Guidance on Tackling Fracture Risk in CKD
After Hip Fracture, Earlier Osteoporosis Drug Initiation Tied to Lower Subsequent Fracture Risk
- 1
- 2
- 3
- …
- 7
- Next Page »